AIGH Capital Management’s Pelthos Therapeutics PTHS Stock Holding History
Bought
Maintained
Sold
Other funds holding PTHS
DMKJ
AIGH Capital Management's PTHS Position: Q3 2026 in Review
AIGH Capital Management reduced its Pelthos Therapeutics (PTHS) stake by 22% in Q3 2026, selling an estimated $1.86M and leaving 256,012 shares worth $5.38M. The position accounts for 0.54% of the portfolio, ranked #30.
AIGH Capital Management first reported a position in PTHS in Q2 2026 and has held it in 2 quarters since. The position peaked at $9.3M in Q2 2026. 29 funds tracked by Wall St. Rank hold PTHS as of Q3 2026.
- AIGH Capital Management held 256,012 shares of Pelthos Therapeutics worth $5.38M as of Q3 2026.
- AIGH Capital Management sold 73,086 Pelthos Therapeutics shares in Q3 2026, an estimated $1.86M.
- Pelthos Therapeutics made up 0.54% of AIGH Capital Management's portfolio in Q3 2026, its #30 holding.
- AIGH Capital Management first reported a position in Pelthos Therapeutics in Q2 2026 and has held it in 2 quarters since.
- AIGH Capital Management's Pelthos Therapeutics position peaked at $9.3M in Q2 2026.
- 29 funds tracked by Wall St. Rank held Pelthos Therapeutics as of Q3 2026.
Based on AIGH Capital Management's 13F filing for Q3 2026, filed 2 Nov 2026.